Stanford, CA: The topical administration of CBD oil is associated with reduced pain and faster wound healing in patients with the skin disease epidermolysis bullosa, according to case reports published in the journal Pediatric Dermatology. Epidermolysis bullosa is a rare genetic condition that results in blistering skin.

Researchers at Stanford University’s School of Medicine and at West Virginia University’s Department of Dermatology reported on the topical use of CBD in three patients with the disease: a six-month-old boy, a three-year-old girl, and a 10-year-old boy. Following CBD administration, “dramatic benefits” were reported by all three patients – including a “reduction in pain and blistering,” “rapid wound healing,” and “the objective need for less analgesic [medicines].” The case-series is the first set of reports to appear in the peer-reviewed literature specific to the use of CBD for the treatment of EB.

For more information, contact Paul Armentano, NORML Deputy Director, at: paul@norml.org. Full text of the study, “Self-initiated use of topical cannabidiol oil for epidermolysis bullosa,” appears in Pediatric Dermatology.

Share this: Twitter

Facebook

